Jeffrey S. Abrams

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · New England Journal of Medicine · 2018 · 2.3K citations · Full text

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741

Marc L. Citron, Donald A. Berry, Constance Cirrincione et al. · Journal of Clinical Oncology · 2003 · 1.6K citations

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

Paul E. Goss, James N. Ingle, Silvana Martino et al. · JNCI Journal of the National Cancer Institute · 2005 · 1.1K citations · Full text

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

Joseph A. Sparano, Robert J. Gray, Peter M. Ravdin et al. · New England Journal of Medicine · 2019 · 532 citations · Full text

How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment Trials

Edward L. Trimble, Jeffrey S. Abrams, Otis W. Brawley et al. · Journal of Clinical Oncology · 2002 · 526 citations